Levels of Vitamin D and their Association with Complications of Type 2 Diabetes Mellituss
DOI:
https://doi.org/10.12970/2310-9971.2019.07.03Keywords:
Diabetic complications, Vitamin D, glycemic control.Abstract
Introduction: Type 2 diabetes mellitus is a non communicable disorder associated with hyperglycemia. It is associated with various micro and macro vascular complications. Vitamin D a stercosterol is an important molecule associated with many skeletal and extra skeletal functions in the body. Vitamin D maintains glucose homeostasis and has an important role to play in manifestations of various complications. Material and Method: The present study comprised of one hundred patients of diabetic complications compared with one hundred normal individuals. All the subjects were investigated for blood glucose, Glycated haemoglobin, lipid profile and vitamin D Results: Glycemic control and lipid profile was deranged in patients with complications of type 2 diabetes mellitus. Levels of vitamin D were significantly decreased in patients as compared to controls. Moreover 73% of the patients were deficient in vitamin D. Conclusions: Vitamin D acts through various non skeletal pathways and helps to regulate glucose. In the current study it showed negative correlation with Glycated Haemoglobin, Triglycerides and Cholesterol thus indicating that maintaining vitamin D levels can delay the onset of diabetic complications.References
[1] Alam U, Devah VA, Javed S, Amalik R. Vitamin D and Diabetic complications. Diabetes Ther 2016; 7: 11-26. https://doi.org/10.1007/s13300-016-0159-x
[2] Asyaonkar SB. Vitamin D and type 2 dibetes mellirus: Indian prespective. Journal of Diabetic Complications and Medicine 2016; l(3): 110-113. https://doi.org/10.4172/2475-3211.1000110
[3] Adela R, Borkar RM, Bhandi MM, et al. Lower Vitamin D Metabolites Levels Were Associated With Increased Coronary Artery Diseases in Type 2 Diabetes Patients in India. Scientific Reports 6: 37593. https://doi.org/10.1038/srep37593
[4] Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-81. https://doi.org/10.2337/dc09-2321
[5] Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-8. https://doi.org/10.1210/jc.2010-2704
[6] Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012; 97: 1146-52. https://doi.org/10.1210/jc.2011-2218
[7] Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26: 455-7. https://doi.org/10.1002/jbmr.328
[8] Holick MF. Vitamin D deficiency N Engl J Med 2007; 357: 266-81. https://doi.org/10.1056/NEJMra070553
[9] MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Investig 1985; 76: 1536-8. https://doi.org/10.1172/JCI112134
[10] Lips P. Vitamin D physiology Prog Biophys Mol Biol 2006; 92: 4-8. https://doi.org/10.1016/j.pbiomolbio.2006.02.016
[11] Kienreich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients 2013; 5: 3005-21. https://doi.org/10.3390/nu5083005
[12] Molinari C, Uberti F, Grossini E, et al. 1a,25-Dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 2011; 27: 661-8. https://doi.org/10.1159/000330075
[13] Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetesmellitus. Circulation 2009; 120: 687-98. https://doi.org/10.1161/CIRCULATIONAHA.109.856070
[14] Tare M, Emmett SJ, Coleman HA, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011; 589: 4777-86. https://doi.org/10.1113/jphysiol.2011.214726
[15] Zoppini G, Galletti A, Targher G, et al. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One 2013; 8: e82733. https://doi.org/10.1371/journal.pone.0082733
[16] Holmoy T, Moen SM. Assessing vitamin D in the central nervous system. Acta Neurol Scand (Suppl.) 2010; 122: 88- 92. https://doi.org/10.1111/j.1600-0404.2010.01383.x
[17] Soilu-Hanninen M, Laaksonen M, Laitinen I, et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 152-7. 55. https://doi.org/10.1136/jnnp.2006.105320
[18] Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010; 67: 808-11. https://doi.org/10.1001/archneurol.2010.120
[19] Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-41. https://doi.org/10.1001/archinternmed.2010.173
[20] Agarwal R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Cli J Am Soc Nephrol 2009; 4: 1523-8. https://doi.org/10.2215/CJN.02010309
[21] Teng M, Wolf M, Lowrie E, et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-56. https://doi.org/10.1056/NEJMoa022536
[22] Golan S, Shalev V, Treister G, Chodick G, Loewenstein A. Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye (Lond) 2011; 25: 1122-9. https://doi.org/10.1038/eye.2011.174
[23] Singh A, Falk MK, Subhi Y, Sorensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in agerelated macular degeneration: a cross-sectional study. PLoS One 2013; 8(7): e70948. https://doi.org/10.1371/journal.pone.0070948
[24] Trinder. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Path 1969; 22: 158-161. https://doi.org/10.1136/jcp.22.2.158
[25] Klenk DC, Hermanson GT, Krohn RI, et al. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clinical Chemistry 1982; 28(10): 2088-2094.
[26] Charles CA, Lucy SP, Cicely S, et al. Enzymatic Determination of Total Serum Cholesterol. Clinical Chemistry 1974; 20(4): 470-475.
[27] Brustein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions J Lipid Res 1970; 11: 583-595.
[28] Michael W, Gowan Mc, Joseph D, et al. A peroxidase coupled method for the colorimetric determination of Serum triglycerides. Clin Chem 1983; 29(3): 538-542.
[29] William T, Friedwald Robert I, Levy and Donald S, Fredrickson. Estimation of concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge Clinical Chemistry 1972; 18(6): 499-502.
[30] Benetti E, et al. Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice. PLoS One 2018; 13: e0189707. https://doi.org/10.1371/journal.pone.0189707
[31] Modi G, Bahediya S, Sharma A. Vitamin d levels and diabetic microvascular complications International Journal of Medical Science and Education 2016; 3(2).
[32] Bajaj S, Singh RP, Dwivedi NC, et al. Vitamin D levels and microvascular complications in type 2 Diabetes. Indian Joiurnal of Endocrinology and Metabolism 2014; 18(4): 537- 41. https://doi.org/10.4103/2230-8210.137512
[33] Scragg R, Sowers M, Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey Diabetes Care 2004; 27: 2813- 8. https://doi.org/10.2337/diacare.27.12.2813
[34] Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc 2013; 88: 720-55. https://doi.org/10.1016/j.mayocp.2013.05.011
[35] Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptidenegative type 1 diabetes. J Clin Endocrinol Metab 2005; 90: 4803-8. https://doi.org/10.1210/jc.2004-2407
[36] Amer M, Qayyum R. Relation between serum 25- hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006) Am J Cardiol 2012; 109: 226-30. https://doi.org/10.1016/j.amjcard.2011.08.032
[37] Zhang Z, Sun L, Wang Y, et al. Reno-protective role of the vitamin D receptor in diabetic nephropathy Kidney Int 2008; 73: 163-71. https://doi.org/10.1038/sj.ki.5002572
[38] Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. Endocr J 2006; 53: 503- 10. https://doi.org/10.1507/endocrj.K06-001
[39] Maser RE, Lenhard MJ, Pohlig RT. Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes. Endocr Pract 2015; 21: 174-81. https://doi.org/10.4158/EP14332.OR
[40] Johnson JA, Grande JP, Roche PC, Kumar R. Immuno histochemical localization of 1,25 (OH) 2 D3 receptor and calbindin D28K in human and rat pancreas Am J Physiol 1994; 267(3Pt1): E356-E360. https://doi.org/10.1152/ajpendo.1994.267.3.E356
[41] Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 1998; 339: 229-234. https://doi.org/10.1056/NEJM199807233390404
[42] Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the framingham heart study 1950 to 2005. Circulation 2009; 119: 1728-1735. https://doi.org/10.1161/CIRCULATIONAHA.108.829176
[43] Oh J, Riek AE, Darwech I, et al. Deletion of macrophage vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice. Cell Reports 2015; 10: 1872-1886. https://doi.org/10.1016/j.celrep.2015.02.043
[44] Herrmann M. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 2015; 38: 521-528. https://doi.org/10.2337/dc14-0180
